-+ 0.00%
-+ 0.00%
-+ 0.00%

Brightening Consumer Sentiment Lifts Swiss Market Index

MT Newswires·12/08/2025 11:58:20
Listen to the news
11:58 AM EST, 12/08/2025 (MT Newswires) -- Swiss stocks kicked off the new trading week in positive territory as markets prepare for a busy week of economic data prints and key monetary policy decisions, with the Swiss Market Index up 0.35% on Monday's close. Switzerland's consumer sentiment moved up to -33.8 points in November from -36.9 points in October, government data showed. In the previous year, the index came in at -37.2 points. The State Secretariat for Economic Affairs said the separate index for economic outlook worsened year over year, while the indicators for past financial situation, financial outlook and moment to make major purchases improved. Meanwhile, the week ahead will see rate decisions from the Swiss National Bank (SNBN.SW) and the US Federal Reserve. Market watchers expect the central bank's policymakers to hold steady in Switzerland and cut by 25 basis points in the US. On the corporate front, Roche (ROG.SW) reported a positive outcome from a three-year follow-up of the phase 3 Starglo study, which showed that Columvi combined with gemcitabine and oxaliplatin prolonged overall survival in patients with relapsed or refractory diffuse large B-cell lymphoma who received at least one previous line of therapy and are not candidates for autologous stem cell transplant, compared with MabThera/Rituxan with gemcitabine and oxaliplatin. The Swiss drugmaker's shares added 2.19% at closing. RBC Capital Markets lowered its rating on Sika (SIKA.SW) to sector perform from outperform, with a price target of 184 francs, anticipating 2026 to be a transition year for the Swiss specialty chemicals company. The stock declined 1.25% at the end of the trading session. "The Group should outperform its respective construction chemicals end-markets, though we don't foresee a market-based recovery until H2'26, with downside risk to 2026 APAC estimates," the research firm wrote. "That said, we forecast EBITDA growth of 7%, in line with the sector, supported by margin expansion. In our view, meaningful re-rating vs the sector will require i) successful progress of the Fast forward program, ii) signs of a Chinese construction recovery."